ANNOUNCEMENT

These 11 companies will be featured in the MedCity ENGAGE Innovation Showcase June 5-6 in Washington, D.C.

Abbott wins FDA approval for heart stent

January 3, 2013 9:07 am by | 0 Comments

(Reuters) - Abbott Laboratories' Xience Xpedition heart stent was approved by U.S. health regulators and will be launched in the United States immediately, the company said on Thursday.

Heart stents are tiny tubular devices that prop open diseased blood vessels after angioplasty. Abbott's stent delivers a drug, everolimus, which helps keep the vessel from reclogging.

Abbott competes with Medtronic Inc and Boston Scientific in the market for heart stents.

Copyright (2013) Thomson Reuters. Click for restrictions

Advertisement

Copyright 2013 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Previous Story

As it awaits regulatory clearance, heart test firm CardiOx opens $4 million round for launch

Next Story

Biogen: Drug for Lou Gehrig’s disease fails late-stage trial

0 comments
  Livefyre
Newest | Oldest

Stay Up To Date

Be the first to hear the latest industry news with our newsletters or by following us on Twitter & Facebook.

Video

GE offers an inside look at how it’s innovating in cancer care (video)

GE offers an inside look at how it’s innovating in cancer care (video)

New York patient portal contest winners take on health literacy challenge

New York patient portal contest winners take on health literacy challenge

Social health network offers discreet way to share, receive health info publicly

Social health network offers discreet way to share, receive health info publicly

5 Hot Startups

Cleveland Clinic and Doximity join up to make earning CME credits more social, flexible

Cleveland Clinic and Doximity join up to make earning CME credits more social, flexible

Health care providers tread carefully with cloud technology

Health care providers tread carefully with cloud technology

Imaging and lab results are begging for an cloud-based makeover

Imaging and lab results are begging for an cloud-based makeover

Mobile technology could save billions of dollars on healthcare costs

Mobile technology could save billions of dollars on healthcare costs

A patient simulator for primary care physicians starts with diabetes

A patient simulator for primary care physicians starts with diabetes

Recent Comments

Research Center

Jobs Board

Next Story
Biogen: Drug for Lou Gehrig’s disease fails late-stage trial
Close